Eli Lilly (LLY) PT Raised to $235 at Cowen After Positive Management Meeting on Donanemab
Tweet Send to a Friend
Cowen analyst Steve Scala raised the price target on Eli Lilly (NYSE: LLY) to $235.00 (from $195.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
